PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease

Neurology

Volumn 84, Issue 10, 2015, Pages 972-980

  Beecham, Gary W ^a   Dickson, Dennis W ^b   Scott, William K ^a   Martin, Eden R ^a   Schellenberg, Gerard ^c   Nuytemans, Karen ^a   Larson, Eric B ^d   Buxbaum, Joseph D ^e   Trojanowski, John Q ^c   Van Deerlin, Vivianna M ^c   Hurtig, Howard I ^c   Mash, Deborah C ^a   Beach, Thomas G ^f,g   Troncoso, Juan C ^h   Pletnikova, Olga ^h   Frosch, Matthew P ^j   Ghetti, Bernardino ^k   Foroud, Tatiana M ^k   Honig, Lawrence S ^l   Marder, Karen ^l   Vonsattel, Jean Paul ^m   Goldman, Samuel M ⁿ   Vinters, Harry V ^o   Ross, Owen A ^b   Wszolek, Zbigniew K ^b   Wang, Liyong ^a   Dykxhoorn, Derek M ^a   Pericak Vance, Margaret A ^a   Montine, Thomas J ^p   Leverenz, James B ^q   Dawson, Ted M ⁱ   Vance, Jeffery M ^a   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f ARIZONA ALZHEIMER S CONSORTIUM   (United States)

^g SUN HEALTH RESEARCH INSTITUTE   (United States)

^h Division of Neuropathology   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^m NewYork Presbyterian Hospital   (United States)

ⁿ PARKINSON S INSTITUTE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^q VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LDLRAD1 PROTEIN; MICRORNA; MICRORNA 4781; PARKIN; PARKIN 10; PROTEIN; TCEANC2 PROTEIN; TMEM59 PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOPSY CONFIRMED PARKINSON DISEASE GENETIC CONSORTIUM; CHROMOSOME 1; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IDIOPATHIC DISEASE; LEWY BODY; LIBRARY SCIENCE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84924386508     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001332     Document Type: Article

References (27)

1. Pankratz N, Beecham GW, DeStefano AL, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol 2012;71:370-384.
2. International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011;377:641-649.
3. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011;7:e1002142.
4. Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010;74:97-109.
5. Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010; 42:781-785.
6. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41:1308-1312.
7. Nalls MA, Pankratz N, Lill CM, et al. Large scale meta analysis of genome-wide association data in Parkinson's disease reveals 6 novel risk loci. Nat Genet 2014;46:989-993.
8. Irwin DJ, White MT, Toledo JB, et al. Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 2012;72:587-598.
9. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neuro-surg Psychiatry 1992;55:181-184.
11. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57:1497-1499.
12. Rajput DR. Accuracy of clinical diagnosis of idiopathic Par kinson's disease. J Neurol Neurosurg Psychiatry 1993;56: 938-939.
13. Holtbernd F, Eidelberg D. The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes. Semin Neurol 2014;34:202-209.
14. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. J Alzheimers Dis 2006;9:417-423.
15. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011;43:436-441.
16. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
17. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491: 56-65.
18. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-913.
19. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinfor-matics 2005;21:263-265.
21. Oliveira SA, Li YJ, Noureddine MA, et al. Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am J Hum Genet 2005;77:252-264.
22. Hicks AA, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002;52:549-555.
23. Li Y, Scott WK, Hedges DJ, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 2002;70:985-993.
24. Wang X, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinfor-matics 2008;24:325-332.
25. Maragkakis M, Alexiou P, Papadopoulos GL, et al. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009;10:295.
26. Noureddine MA, Li YJ, van der Walt JM, et al. Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra. Mov Disord 2005;20:1299-1309.
27. Ullrich S, Munch A, Neumann S, Kremmer E, Tatzelt J, Lichtenthaler SF. The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein. J Biol Chem 2010;285:20664-20674.